February 23, 2015 — C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
Drug-eluting balloons (DEBs), also referred to as drug-coated balloons (DCBs), have been one of the long-awaited new ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
February 13, 2015 — Boston Scientific and C. R. Bard announced a deal where Boston Scientific will distribute the ...
February 13, 2015 — Shimadzu Medical Systems announced the first United States installation of its Trinias C-12 ...
February 6, 2015 — United States hospitals began using a new medical device from Medtronic plc called the In.Pact ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
February 3, 2015 — Coronary bypass graft surgery commonly used to treat patients with coronary heart disease results in ...
February 2, 2015 — New clinical research is essential to the development of hospital quality measurement, public ...
January 30, 2015 — ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
There are several new interventional and minimally invasive surgical heart failure (HF) devices in development or in ...
January 28, 2015 — Neovasc Inc. has commenced a public offering in the United States of 8 million shares of the company ...
January 28, 2015 — Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
January 22, 2015 — AstraZeneca announced that the PEGASUS-TIMI 54 study, a large-scale outcomes trial involving more ...
The America College of Cardiology has released its list of key late-breaking clinical trials at the ACC 2015 meeting in ...
January 16, 2015 — Bellerophon Therapeutics LLC said it completed enrollment of its PRESERVATION I clinical trial of ...
February 23, 2015